TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

First Page		Document Content
Health economics Healthcare quality Immunosuppressants Orphan drugs Costs Disease-modifying antirheumatic drug Tocilizumab Rituximab Quality-adjusted life year Rheumatoid arthritis Etanercept TNF inhibitor		TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS Add to Reading List Source URL: www.nicedsu.org.uk Download Document from Source Website File Size: 229,84 KB Share Document on Facebook

	Emergency Severity Index, Version 4: Implementation Handbook Agency for Healthcare Research and Quality DocID: 1vq4T - View Document
	The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is committed to presenting CME activities that promote improvements or quality in healthcare and are independent of the control of comm DocID: 1vlRH - View Document
	Agency for Healthcare Research and Quality Center for Quality Improvement and Patient Safety Longitudinal Program Evaluation of the HHS Action Plan to Prevent Healthcare‐Associated Infecti DocID: 1vhhP - View Document
	NTUC Unity Launches Own Range of Essential Vitamins/Supplements, Housebrand Aims to Deliver Better “Value” “Unity” housebrand offers assured quality and affordable healthcare supplements; Vitamins are priced to r DocID: 1uTrn - View Document
	Cosmedent Contribution Supports America’s ToothFairy Programs for Children in Need (May 30, 2017, Charlotte, NC)– Underserved children around the nation will have increased access to quality oral healthcare thanks to DocID: 1uSpY - View Document